Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation

Bone Marrow Transplantation volume 26, pages 1005–1009 (2000)Cite this article

Abstract

Thrombotic thrombocytopenic purpura (TTP) has emerged as one of the main transplant-related complications over the last 15 years. The current study defines the incidence and the risk factors for the occurrence of TTP in 131 consecutive leukemic children who were transplanted between January 1994 and December 1997 at four Italian pediatric centers. Patients with ALL (101), AML (21), MDS (9), underwent an HLA-identical sibling BMT (82) or an HLA-identical unrelated BMT (49), receiving a conditioning regimen consisting of high-dose chemotherapy in 24 patients and of F-TBI combined with high-dose chemotherapy in 107 patients. The diagnosis of TTP was retrospectively evaluated on the basis of parallel criteria. TTP treatment varied according to the protocol of each treatment center. Twenty-eight of 131 patients (21.4%) developed TTP at a median of 46 days (range 21–80) after BMT. Multivariate analysis demonstrated that the risk of TTP was higher in patients who underwent unrelated BMT (P value = 0.02). Acute GVHD, stage of disease at BMT, conditioning with TBI, gender, age, did not appear to be associated with the occurrence of TTP. As to the outcome, TTP resolved in 19 patients while in nine it was the principal cause of death (32.1%). In patients with TTP, LDH peak value was the only statistically significant factor (P = 0.001) related to severe TTP. In conclusion, our experience demonstrates that leukemic children undergoing BMT, especially from an unrelated donor, should be carefully assessed for TTP which appears to be a severe and relatively common transplant-related complication when strict diagnostic criteria are applied. Bone Marrow Transplantation (2000) 26, 1005–1009.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Spruce WE, Forman SJ, Blume KG et al. Hemolytic uremic syndrome after bone marrow transplantation Acta Haematol 1982 67: 206–210

    Article  CAS  PubMed  Google Scholar 

  2. Juckett M, Perry EH, Daniels BS et al. Hemolytic uremic syndrome following bone marrow transplantation Bone Marrow Transplant 1991 7: 405–409

    CAS  PubMed  Google Scholar 

  3. Holler E, Kolb JH, Hiller F et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-vs-host-disease after HLA-identical bone marrow transplantation Blood 1989 73: 2018–2024

    CAS  PubMed  Google Scholar 

  4. Pettitt AR, Clark RE . Thrombotic microangiopathy following bone marrow transplantation Bone Marrow Transplant 1994 14: 495–504

    CAS  PubMed  Google Scholar 

  5. Valilis PH, Zeigler ZR, Shadduck RK et al. A prospective study of bone marrow transplant associated thrombotic microangiopathy (BMT-TM) in autologous and allogeneic BMT Blood 1995 86: 970a (Abstr.)

    Google Scholar 

  6. Schriber JR, Herzig GP . Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Semin Hematol 1997 34: 126–133

    CAS  PubMed  Google Scholar 

  7. Zeigler ZR, Shadduck RK, Nemumaitis J et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series Bone Marrow Transplant 1995 15: 247–253

    CAS  PubMed  Google Scholar 

  8. Iacopino P, Pucci G, Arcese W et al. Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation Bone Marrow Transplant 1999 24: 47–51

    Article  CAS  PubMed  Google Scholar 

  9. George JM, Berkowitz SD, Raskob GE . Platelets: acute thrombocytopenia – thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. The ASH Meeting Blood Education Program Book 1998 379–383

  10. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the acute leukemias: French–American–British (FAB) Cooperative Group Br J Haematol 1976 33: 451–458

    Article  CAS  PubMed  Google Scholar 

  11. Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French–American–British cooperative group Ann Intern Med 1985 103: 626–629

    Article  Google Scholar 

  12. Sullivan KM . Graft versus host disease. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic Cell Transplantation 2nd edn. Blackwell Science: USA 1999 pp 515–536

    Google Scholar 

  13. Uderzo C, Valsecchi MG, Bacigalupo A et al. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology oncology Association J Clin Oncol 1995 13: 352–358

    Article  CAS  PubMed  Google Scholar 

  14. Van Lint MT, Uderzo C, Locasciulli A et al. Early treatment of acute graft-vs-host disease with high or low dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation Blood 1998 92: 2288–2293

    CAS  PubMed  Google Scholar 

  15. Hosmer DN, Lemeshow S . Applied Logistic Regression Wiley & Sons: New York 1989 pp 25–36

    Google Scholar 

  16. Busca A, Uderzo C . Bone marrow transplant associated thrombotic microangiopathy Hematology 2000 5: 53–67

    Article  PubMed  Google Scholar 

  17. Kondo M, Kojima S, Horibe K et al. Hemolytic uremic syndrome after allogeneic or autologous hemapoietic stem cell transplantation for childhood malignancies Bone Marrow Transplant 1998 21: 281–286

    Article  CAS  PubMed  Google Scholar 

  18. Guinan EC, Tarbell J, Niemeyer CM et al. Intravascular hemolysis and renal insufficiency after BMT Blood 1998 72: 451–455

    Google Scholar 

  19. Rock AG, Shumak KH, Buskard NA . et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura New Engl J Med 1991 325: 393–397

    Article  CAS  PubMed  Google Scholar 

  20. Dua A, Zeigler Z, Shadduck RK et al. Apheresis in grade four bone marrow transplant associated thrombotic microangiopathy: a case series J Clin Apheresis 1996 11: 176–184

    Article  CAS  PubMed  Google Scholar 

  21. Sarode R, McFarland JC, Flamemberg N et al. Therapeutic plasma exchange does not appear to be effective in the management of TTP and hemolytic uremic syndrome following bone marrow transplantation Bone Marrow Transplant 1995 16: 271–275

    CAS  PubMed  Google Scholar 

  22. Zeigler ZR, Shadduck RK, Nath R et al. Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3–4 bone marrow transplantation associated thrombotic microangiopathy Bone Marrow Transplant 1996 17: 81–86

    CAS  PubMed  Google Scholar 

  23. Wada H, Kaneko T, Ohiwa M et al. Plasma cytokine levels in thrombotic thrombocytopenic purpura Am J Hematol 1992 40: 167–170

    Article  CAS  PubMed  Google Scholar 

  24. Krenger W, Hill GR, Ferrara JLM . Cytokine cascades in acute graft-versus-host disease Transplantation 1997 64: 553–558

    Article  CAS  PubMed  Google Scholar 

  25. Chong BH, Murray B, Berndt MC et al. Plasma P-selectin is increased in thrombotic consumptive platelet disorders Blood 1994 83: 1535–1541

    CAS  PubMed  Google Scholar 

  26. Anthony MT, Zeigler ZR, Lister J et al. Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post bone marrow transplantation Am J Hematol 1998 59: 9–14

    Article  CAS  PubMed  Google Scholar 

  27. Moake JL, Rudy CK, Troll JH . Unusually large plasma VIII von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura New Engl J Med 1982 307: 1432–1436

    Article  CAS  PubMed  Google Scholar 

  28. Natazuka T, Kajimoto K, Ogawa R et al. Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantion from HLA-matched unrelated donors in patients with hematological malignancies Bone Marrow Transplant 1998 21: 815–819

    Article  CAS  PubMed  Google Scholar 

  29. Llamas P, Romero R, Cabrera R et al. Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange? Bone Marrow Transplant 1997 20: 305–306

    Article  CAS  PubMed  Google Scholar 

  30. Clark WF, Rock GA, Buskard N et al. Therapeutic plasma exchange: an update from Canadian Apheresis Group Ann Intern Med 1999 131: 453–462

    Article  CAS  PubMed  Google Scholar 

  31. Atkinson K, Biggs JC, Hayes J . Cyclosporin A associated nephrotoxicity in the first 100 days after BMT: three distinct syndromes Br J Haematol 1983 54: 59–67

    Article  CAS  PubMed  Google Scholar 

  32. Srivastava A, Gottlieb D, Bradstock KF . Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation Bone Marrow Transplant 1995 15: 863–867

    CAS  PubMed  Google Scholar 

  33. Carlson K, Smedmyr B, Hagberg H et al. Haemolytic uraemic syndrome and renal disfunction following BEAC (BCNU, etoposide, ara-c, cyclophosphamide) plus/minus TBI and autologous BMT for malignant lymphomas Bone Marrow Transplant 1993 11: 205–208

    CAS  PubMed  Google Scholar 

  34. Uderzo C, Fumagalli M, De Lorenzo P et al. Thrombotic thrombocytopenic purpura (TTP) as early complication in children who undergo bone marrow transplantation Blood 1999 94:: (Suppl. 1) 363b (Abstr.)

    Google Scholar 

  35. Hamblin N, Powles R, Treleaven J et al. Defibrotide for refractory thrombotic thrombocytopenic purpura after bone marrow transplantation Blood 1996 88: (10 Suppl.) 2966

    Google Scholar 

  36. Bayik MM, Akoglu T, Tuglular TF et al. Treatment of TTP with defibrotide Am J Hematol 1993 43: 74–75

    Article  CAS  PubMed  Google Scholar 

  37. Mantovani M, Primo G, Pescador R . Activation of fibrinolytic process by a substance of polydesoxyriboneucleotidic nature (fraction P), in strand, advance in coagulation, fibrinolysis and platelet aggregation and aterosclerosis. CEPI: Rome 1978 pp 274–281

  38. Violi F, Ferro D, Alessandri C et al. Inhibition of tissue plasminogen activator inhibitor by defibrotide in aterosclerotic patients Semin Thromb Haematol 1989 15: 226–229

    Article  CAS  Google Scholar 

  39. Pogliani EM, Salvatore M, Foust C et al. Effects of defibrotide-heparin combination of some measures of haemostasis in health volunteers J Intern Med Res 1989 17: 36–40

    Article  CAS  Google Scholar 

  40. Richardson PG, Elias AD, Krishnan A . Treatment of severe venoocclusive disease with defibrotide: compassionate use results in response without significant toxicity in high-risk population Blood 1998 92: 737–744

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the ‘Comitato Maria Letizia Verga per lo Studio e Cura della Leucemia del Bambino’, the Associazione Italiana Ricerca Cancro and Miss Joanna Upton for her language review.

Author information

Authors and Affiliations

  1. Clinica Pediatrica Ospedale S Gerardo di Monza, Università degli Studi di Milano Bicocca, Italy

    C Uderzo, M Fumagalli, S Bonanomi & A Balduzzi

  2. Dipartimento di Medicina e Salute Pubblica, Università degli studi di Verona, Italy

    P De Lorenzo & MG Valsecchi

  3. Clinica Pediatrica II, Università di Torino, Italy

    A Busca, E Vassallo & R Miniero

  4. Istituto G Gaslini, Genova, Italy

    E Lanino & G Dini

  5. Clinica Pediatrica II, Università di Padova, Italy

    S Varotto & C Messina

Authors
  1. C Uderzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Fumagalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P De Lorenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Busca
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Vassallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Bonanomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E Lanino
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G Dini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Varotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C Messina
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. R Miniero
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. MG Valsecchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. A Balduzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uderzo, C., Fumagalli, M., De Lorenzo, P. et al. Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. Bone Marrow Transplant 26, 1005–1009 (2000). https://doi.org/10.1038/sj.bmt.1702648

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702648

Keywords

This article is cited by

Search

Advanced search

Quick links